Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia
3d agoen
From the article
Conditions : Mycosis Fungoides/Sezary Syndrome; T-cell Large Granular Lymphocytic Leukemia Interventions : Drug: Golidocitinib Sponsors : Washington University School of Medicine; Dizal Pharmaceuticals Not yet recruiting
Continue reading on clinicaltrials.gov
Comments
Sign in to join the conversation.
No comments yet. Be the first.